The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs. All eventually passed muster.
Related Posts
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
A Chinese company targeted by members of Congress over potential ties to the Chinese government makes blockbuster drugs for the…
Sick Prisoners in New York Were Granted Parole but Remain Behind Bars
Prisons across the country are struggling to find nursing home placements for sick prisoners after granting them parole. In New…
How Foreign Aid Cuts Are Setting the Stage for Disease Outbreaks
Organizations funded by the United States helped keep dangerous pathogens in check around the world. Now many safeguards are gone,…